Antares Pharma, Inc.
Antares Pharma, Eli Lilly file joint patent application for needle-free injection device
Published in Medicine and Law Weekly, June 30th, 2006
This agreement provides for development of needle-free injection devices in the fields of diabetes and obesity. The filing incorporates development work focused on making products more patient friendly related to the Antares' core needle-free injector technology. This work could enhance the needle-free technology that Antares already sells into the U.S. insulin market as the MediJector Vision.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- American Association for the Study of Liver Diseases
Education and guidelines needed for genetic testing in liver disease - Avid Radiopharmaceuticals, Inc.
Avid Radiopharmaceuticals adds three industry veterans - BioProgress plc
BioProgress subsidiary files patent application for use of XGEL film system - BioTechnology GmbH
BioTechnology reports basis patent for Sloning gene synthesis technology was granted - Boston Scientific Corporation
Court of Appeals rules Boston Scientific's products do not infringe Medtronic stent patents - Chimerix, Inc.
Chimerix acquires compound library of antiviral agents from University of Michigan - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
